Showing results (11-20 of 220) with videos related to
Sort By:
Pageof 22
Journal of Virology|October 24, 2008
Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3HAriana Harari, Marcel Ooms, Lubbertus C F Mulder, et al.Virology|August 5, 2011
Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoterMatthew S Dahabieh, Marcel Ooms, Tom Malcolm, et al.Journal of Virology|June 4, 2010
The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activityMarcel Ooms, Susan Majdak, Christopher W Seibert, et al.Journal of Virology|March 30, 2012
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1Marcel Ooms, Aikaterini Krikoni, Andrea K Kress, et al.AIDS (London, England)|April 12, 2016
Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypesKavidha Reddy, Marcel Ooms, Michael Letko, et al.Journal of Virology|December 30, 2011
Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factorsJudd F Hultquist, Mawuena Binka, Rebecca S LaRue, et al.Plos Pathogens|October 5, 2005
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversificationViviana Simon, Veronique Zennou, Deya Murray, et al.Journal of Virology|July 27, 2018
Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and MiceFelix Broecker, Sean T H Liu, Weina Sun, et al.Virology|November 18, 2006
Characterization of HIV-1 integrase N-terminal mutant virusesAliza G Lloyd, Yen Shing Ng, Mark A Muesing, et al.Vaccines|June 19, 2019
An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus AntibodiesMohammad Amin Behzadi, Kathryn R Stein, Maria Carolina Bermúdez-González, et al.Pageof 22